IR@PKUHSC  > 北京大学药学院
学科主题药学
Antiviral flavonoid-type C-glycosides from the flowers of Trollius chinensis
Cai, SQ; Wang, RF; Yang, XW; Shang, MY; Ma, CM; Shoyama, Y
刊名CHEMISTRY & BIODIVERSITY
2006
3期:3页:343-348
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemistry & Molecular Biology ; Chemistry, Multidisciplinary
研究领域[WOS]Biochemistry & Molecular Biology ; Chemistry
关键词[WOS]LEDEBOURI
英文摘要

Two new flavonoid-type C-glycosides, trollisin I (=(IS)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5hydroxy-7-nietlioxy-4-oxo4H-[1]benzopyran-8-yl]-2-O-(2-methylbutanoyl)-D-glucitol; 1) and its 2-O-benzoyl congener trollisin II (2), were isolated from Trollius chinensis BUNGE, together with the two known compounds 2 ′′-O-(2 ′′′-methylbutanoyl)isoswertisin (3) and vitexin galactoside (4). All compounds were identified by HR-ESI-MS and in-depth NMR-spectroscopic analyses. In antiviral assays, compound 3 was found to be moderately active towards influenza virus A.

语种英语
WOS记录号WOS:000236523400009
引用统计
被引频次:33[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61708
专题北京大学药学院
作者单位1.Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China
2.Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan
推荐引用方式
GB/T 7714
Cai, SQ,Wang, RF,Yang, XW,et al. Antiviral flavonoid-type C-glycosides from the flowers of Trollius chinensis[J]. CHEMISTRY & BIODIVERSITY,2006,3(3):343-348.
APA Cai, SQ,Wang, RF,Yang, XW,Shang, MY,Ma, CM,&Shoyama, Y.(2006).Antiviral flavonoid-type C-glycosides from the flowers of Trollius chinensis.CHEMISTRY & BIODIVERSITY,3(3),343-348.
MLA Cai, SQ,et al."Antiviral flavonoid-type C-glycosides from the flowers of Trollius chinensis".CHEMISTRY & BIODIVERSITY 3.3(2006):343-348.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Cai, SQ]的文章
[Wang, RF]的文章
[Yang, XW]的文章
百度学术
百度学术中相似的文章
[Cai, SQ]的文章
[Wang, RF]的文章
[Yang, XW]的文章
必应学术
必应学术中相似的文章
[Cai, SQ]的文章
[Wang, RF]的文章
[Yang, XW]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。